The Economic Times
October 22, 2003
Labs gets patents for 3 active ingredients
SAMI Labs, a Bangalore based Rs 250 crore biotech firm, has
been granted three patents for new active ingredients in the
fields of dermatology and infective & geriatric ophthalmology.
Muhammed Majeed, chairman & MD, Sami Labs, told ET that
the patents will pave the way for a renewed focus on discovery
and intellectual property.
The three patented active ingredients- Tetrahydrocurcuminoids
(THC), Coleus oil and Zealutien- are expected to revolutionise
the dermatology, infective and geriatric ophthalmology markets.
are the white curcuminoids converted from the yellow active
ingredient in turmeric. The component has significant antioxidant
application and UV protection. The process of conversion
from yellow to white improves bio-availability and eliminates
the staining properties of curcuminoids. The process of
stabilisation of lutein improves the longevity of a drug
and its preventive capabilities. The oil extracted from
Coleus Forskohli has strong anti-microbial properties, especially
in fighting gram positive infections and dental microbial
ingredients in nutraceuticals and cosmeceuticals formulations
have a market size of Rs 20 crore. Sami plans to capture
5% of the market in the next three years.